(MENAFN- Investor Brand Network) U.S. Food and Drug Administration (FDA) director Robert Califf noted before a House committee on April 11, 2024, that
there is no justification
for the U.S. Drug Enforcement Administration (DEA) to postpone making the much-anticipated decision to move cannabis from Schedule I to III of the Controlled Substances Act (CSA).
However, Califf suggested that the DEA might treat recreational cannabis differently from medical cannabis, a move that could significantly impact the...
Read More>>
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive SMS alerts from CNW, text
CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published:
/Disclaimer
CannabisNewsWire
Denver, CO
303.498.7722 Office
...
CannabisNewsWire is powered by
IBN
MENAFN22042024000224011066ID1108125746
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.